A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma
Clinical trial NCT00804908 · COMPLETED
Trial details
- NCT number
- NCT00804908
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2016-01-01
- Enrollment
- 346
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.